Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Synlogic ( (SYBX) ).
On November 21, 2025, Synlogic received a notice from Nasdaq’s Listing Qualifications Department stating that, based on its review of the company’s public disclosures, it believed Synlogic had become a public shell and that continued listing of its securities was no longer warranted, with a suspension and delisting targeted for December 2, 2025 unless the company requested a hearing. Synlogic requested such a hearing on November 28, 2025, temporarily staying any suspension, but after further consideration withdrew its hearing request on January 16, 2026, leading Nasdaq that same day to notify the company that trading in its shares will be suspended at the open of business on January 21, 2026 and that a delisting filing with the SEC will follow. Synlogic plans for its common stock to be quoted on the OTC Markets following the Nasdaq delisting, and it will remain an SEC-reporting company, with the transition expected not to affect its underlying business operations, though it shifts its market presence from a national exchange to an over-the-counter platform.
The most recent analyst rating on (SYBX) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Synlogic stock, see the SYBX Stock Forecast page.
Spark’s Take on SYBX Stock
According to Spark, TipRanks’ AI Analyst, SYBX is a Neutral.
The score is primarily held down by weak financial performance (no meaningful revenue, ongoing losses and negative cash flow, and a shrinking equity/asset base). Technicals remain bearish on longer-term moving averages, and valuation is not supportive due to negative earnings and no dividend. Added downside risk comes from the Nasdaq delisting notice and related uncertainty.
To see Spark’s full report on SYBX stock, click here.
More about Synlogic
Synlogic, Inc. is a publicly traded biotechnology company whose common stock has been listed on the Nasdaq Capital Market, providing investors access to its shares through a major U.S. securities exchange.
Average Trading Volume: 44,195
Technical Sentiment Signal: Strong Sell
Current Market Cap: $13.1M
For an in-depth examination of SYBX stock, go to TipRanks’ Overview page.